Company intelligence / Profile preview

Brace Pharma Capital

Rockville, Maryland, United Statesbracepharma.com ↗

Ownership: Private
Development stage: Other

Overview

Brace Pharma Capital is a strategic investment firm focused on innovative therapies for diseases with high unmet medical need. It invests in early and late-stage life sciences companies developing novel therapeutics across multiple modalities and indications. Clinical results pertain to its portfolio companies.

Modalities: Small moleculeAntibodyRNA therapy
Industry: Investors

Partnerships

Pipeline TherapeuticsmiRagen TherapeuticsZymeworksReViralUnum TherapeuticsGliknik

Beyond the preview

Go deeper on Brace Pharma Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Brace Pharma Capital.

Explore the full profile